Cargando…
RUSC1‐AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR‐326/XRCC5 pathway
BACKGROUND: Many long noncoding RNAs (lncRNAs) are the key regulators for cancer progression, including breast cancer (BC). RUSC1 antisense 1 (RUSC1‐AS1) has been found to be highly expressed in BC, but its role and potential molecular mechanism in BC remain to be further elucidated. METHODS: Quanti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447167/ https://www.ncbi.nlm.nih.gov/pubmed/37429610 http://dx.doi.org/10.1111/1759-7714.15035 |
_version_ | 1785094495531958272 |
---|---|
author | Ayoufu, Aisikeer Paierhati, Puerkaiti Qiao, Lei Zhang, Nan Abudukeremu, Muzhapaer |
author_facet | Ayoufu, Aisikeer Paierhati, Puerkaiti Qiao, Lei Zhang, Nan Abudukeremu, Muzhapaer |
author_sort | Ayoufu, Aisikeer |
collection | PubMed |
description | BACKGROUND: Many long noncoding RNAs (lncRNAs) are the key regulators for cancer progression, including breast cancer (BC). RUSC1 antisense 1 (RUSC1‐AS1) has been found to be highly expressed in BC, but its role and potential molecular mechanism in BC remain to be further elucidated. METHODS: Quantitative reverse transcription‐polymerase chain reaction (RT‐PCR) was utilized to measure RUSC1‐AS1, microRNA (miR)‐326 and X‐ray repair cross‐complementing group 5 (XRCC5) expression. Cell proliferation, metastasis, cell cycle, apoptosis and angiogenesis were determined by cell counting kit‐8, colony formation, transwell, flow cytometry and tube formation assays. Protein expression was detected by western blot analysis. The targeted relationship between miR‐326 and RUSC1‐AS1 or XRCC5 was validated using dual‐luciferase reporter assay and RIP assay. Xenograft models were constructed to uncover the effect of RUSC1‐AS1 on BC tumorigenesis. RESULTS: RUSC1‐AS1 was upregulated in BC, and its downregulation suppressed BC proliferation, metastasis, cell cycle, angiogenesis, and tumor growth. MiR‐326 was confirmed to be sponged by RUSC1‐AS1, and its inhibitor reversed the regulation of RUSC1‐AS1 silencing on BC progression. XRCC5 could be targeted by miR‐326. Overexpression of XRCC5 reversed the inhibitory impacts of miR‐326 on BC progression. CONCLUSION: RUSC1‐AS1 could serve as a sponge of miR‐326 to promote BC progression by targeting XRCC5, suggesting that RUSC1‐AS1 might be a target for BC treatment. |
format | Online Article Text |
id | pubmed-10447167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-104471672023-08-24 RUSC1‐AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR‐326/XRCC5 pathway Ayoufu, Aisikeer Paierhati, Puerkaiti Qiao, Lei Zhang, Nan Abudukeremu, Muzhapaer Thorac Cancer Original Articles BACKGROUND: Many long noncoding RNAs (lncRNAs) are the key regulators for cancer progression, including breast cancer (BC). RUSC1 antisense 1 (RUSC1‐AS1) has been found to be highly expressed in BC, but its role and potential molecular mechanism in BC remain to be further elucidated. METHODS: Quantitative reverse transcription‐polymerase chain reaction (RT‐PCR) was utilized to measure RUSC1‐AS1, microRNA (miR)‐326 and X‐ray repair cross‐complementing group 5 (XRCC5) expression. Cell proliferation, metastasis, cell cycle, apoptosis and angiogenesis were determined by cell counting kit‐8, colony formation, transwell, flow cytometry and tube formation assays. Protein expression was detected by western blot analysis. The targeted relationship between miR‐326 and RUSC1‐AS1 or XRCC5 was validated using dual‐luciferase reporter assay and RIP assay. Xenograft models were constructed to uncover the effect of RUSC1‐AS1 on BC tumorigenesis. RESULTS: RUSC1‐AS1 was upregulated in BC, and its downregulation suppressed BC proliferation, metastasis, cell cycle, angiogenesis, and tumor growth. MiR‐326 was confirmed to be sponged by RUSC1‐AS1, and its inhibitor reversed the regulation of RUSC1‐AS1 silencing on BC progression. XRCC5 could be targeted by miR‐326. Overexpression of XRCC5 reversed the inhibitory impacts of miR‐326 on BC progression. CONCLUSION: RUSC1‐AS1 could serve as a sponge of miR‐326 to promote BC progression by targeting XRCC5, suggesting that RUSC1‐AS1 might be a target for BC treatment. John Wiley & Sons Australia, Ltd 2023-07-10 /pmc/articles/PMC10447167/ /pubmed/37429610 http://dx.doi.org/10.1111/1759-7714.15035 Text en © 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Ayoufu, Aisikeer Paierhati, Puerkaiti Qiao, Lei Zhang, Nan Abudukeremu, Muzhapaer RUSC1‐AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR‐326/XRCC5 pathway |
title | RUSC1‐AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR‐326/XRCC5 pathway |
title_full | RUSC1‐AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR‐326/XRCC5 pathway |
title_fullStr | RUSC1‐AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR‐326/XRCC5 pathway |
title_full_unstemmed | RUSC1‐AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR‐326/XRCC5 pathway |
title_short | RUSC1‐AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR‐326/XRCC5 pathway |
title_sort | rusc1‐as1 promotes the malignant progression of breast cancer depending on the regulation of the mir‐326/xrcc5 pathway |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447167/ https://www.ncbi.nlm.nih.gov/pubmed/37429610 http://dx.doi.org/10.1111/1759-7714.15035 |
work_keys_str_mv | AT ayoufuaisikeer rusc1as1promotesthemalignantprogressionofbreastcancerdependingontheregulationofthemir326xrcc5pathway AT paierhatipuerkaiti rusc1as1promotesthemalignantprogressionofbreastcancerdependingontheregulationofthemir326xrcc5pathway AT qiaolei rusc1as1promotesthemalignantprogressionofbreastcancerdependingontheregulationofthemir326xrcc5pathway AT zhangnan rusc1as1promotesthemalignantprogressionofbreastcancerdependingontheregulationofthemir326xrcc5pathway AT abudukeremumuzhapaer rusc1as1promotesthemalignantprogressionofbreastcancerdependingontheregulationofthemir326xrcc5pathway |